Activity Monitors As a Measure of Physical Function in Degenerative Cervical Myelopathy
Launched by UNIVERSITY OF UTAH · Jul 30, 2020
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Degenerative cervical myelopathy (DCM) is the most common cause of spinal dysfunction across the world and a major cause of disability. DCM describes a group of conditions that progressively impinge on the spinal cord resulting in functional impairment and a reduced quality of life. Degenerative diseases of the spine increase in prevalence with increases in age. A cadaver study of 469 adults found cervical stenosis of at least one level in 19.2% of adults, 24.5% in those older than 50 and 27% of those older than 70 years. By 2050 the global population over 60 years of age is expected to app...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 18 +
- • Without known injuries or compounding disability
- • Without prior-to-injury activity limitations
- • Moderate to severe degenerative cervical pathology
- • Undergoing decompression surgery
- • Has a personal smartphone with the capability to download the Fitbit app.
- Exclusion Criteria:
- • Unable or unwilling to comply with study protocol
- • Known injuries or compounding disability
- • Prior-to-injury activity limitations
- • Inability to ambulate
About University Of Utah
The University of Utah is a prestigious research institution known for its commitment to advancing medical knowledge and improving patient care through innovative clinical trials. With a robust infrastructure that supports a wide range of biomedical research initiatives, the university leverages its multidisciplinary expertise and state-of-the-art facilities to conduct rigorous clinical studies. By fostering collaboration among researchers, clinicians, and community partners, the University of Utah aims to translate scientific discoveries into effective therapies and interventions, ultimately enhancing health outcomes and contributing to the advancement of medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Salt Lake City, Utah, United States
Patients applied
Trial Officials
Ryan Spiker, M.D.
Principal Investigator
University of Utah
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials